An observational study in Prader-Willi Syndrome, sponsored by Foundation for Prader-Willi Research. Completed at 1 site in United States. Open to participants aged 5 Years and older. Per ClinicalTrials.gov, last updated 2024-02-29.
Sponsored by Foundation for Prader-Willi Research · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 69 studies in Prader-Willi Syndrome with a site in United States — 9 open to participants now, 14 under way, 3 of them phase 3. Prader-Willi Syndrome · United States.
Among the 69 studies in Prader-Willi Syndrome with a site in United States, this one is the 4th largest by enrollment of the 11 observational ones that give a count, is one of 10 that started in 2018, is one of 11 observational ones, and was the 36th registered.
144 studies on the registry are indexed under Prader-Willi Syndrome; 23 are open to participants now.
Browse Prader-Willi Syndrome studies →9 of the 69 studies in Prader-Willi Syndrome with a site in United States are open now. Recruiting first, the newest first:
Children's Mercy Hospital Kansas City · Sites in United States
Ages 13–17
ConSynance Therapeutics · Sites in United States
Ages 13–50
Grace Kim · Sites in United States
Ages 18–26
University of North Carolina, Chapel Hill · Sites in United States
Ages 18+ · Healthy volunteers
Harmony Biosciences Management, Inc. · Sites in United States, Australia, Belgium and 10 more countries
Ages 6+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 16 Prader-Willi Syndrome studies recruiting now, 7 (44%) set no upper age limit and 9 (56%) stop at 75 or younger; 11 take children under 18; 1 takes healthy volunteers.
This study: 5 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
69 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 7 · Phase 2 23 · Phase 3 16 · Phase 4 3
First in 1999; this study’s year is marked. 10 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 700 is above the median of 51 across 36 observational studies indexed under Prader-Willi Syndrome.
Median enrollment 23 across the 58 interventional studies, 200 across the 11 observational. Of the 51 that completed or were terminated, 21 (41%) have results posted.
This tab as a report to print or save as PDF → With an account.
32 of 69 have an industry lead sponsor. The 10 most frequent:
Foundation for Prader-Willi Research is the lead sponsor of 3 studies on the registry; none are open to participants now.
Foundation for Prader-Willi Research has 2 studies filed under Prader-Willi Syndrome — fewer than ten, so there is no comparison to draw.
7 of the studies in Prader-Willi Syndrome with a site in United States that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06366464Phase 3Harmony Biosciences Management, Inc.A Study of Pitolisant in Patients With Prader-Willi Syndrome | 2027-04 |
| NCT06144645Phase 3Foundation for Prader-Willi ResearchA Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWS | 2027-04-01 |
| NCT03655223RTI InternationalEarly Check: Expanded Screening in Newborns | 2026-11-30 |
| NCT06239116Rhythm Pharmaceuticals, Inc.A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment | 2027-05-07 |
| NCT07348601ConSynance TherapeuticsA Study of CSTI-500 in Patients With Prader-Willi Syndrome | 2027-06 |
Add all 7 to your calendar (.ics) → With an account.
Among the 69 studies in Prader-Willi Syndrome with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
PATH for PWS is a study to help researchers better understand serious medical events in PWS over a 4-year period, as well as evaluate how PWS-related behaviors change over time. The data from this study is intended to inform the development and clinical trial design of potential new treatments.
Every 6 months, participants or their caregivers will be asked to update online surveys about medical problems and serious medical events, as well as provide information about conditions and behaviors often associated with PWS such as hyperphagia. Because this is an observational study, no study drug will be provided and no visits to a doctor or clinic are required.
Participants with PWS who are at least 5 years old and live in the United States, Canada, Australia, or New Zealand
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Participants must meet all of the following criteria:
Participants or their caregiver must also meet all of the following criteria:
Exclusion Criteria:
Participants or their caregiver meeting any of the following criteria will be excluded:
Evaluate the incidence of serious medical events
Serious medical events are those that result in death, are life-threatening, require hospitalization or an emergency room visit, or are medically significant
Time frame: Up to 4 years
Evaluate the incidence of non-serious thrombotic events
Thrombotic events include blood clots in a blood vessel, such as an artery or vein
Time frame: Up to 4 years
Analyze D-dimer concentrations in a subset of participants who agree to provide a blood sample
D-dimer is a protein in the blood that is present when a blood clot is forming or has formed
Time frame: Up to 4 years
Evaluate prescription medication use associated with serious medical events and thrombotic events
Time frame: Up to 4 years
Evaluate the change in weight
Time frame: Up to 4 years
Evaluate the change in height
Time frame: Up to 4 years
Evaluate the change in height-adjusted weight
Time frame: Up to 4 years
Evaluate PWS complexity using an online survey
Time frame: Up to 4 years
Evaluate the pattern of hyperphagia behaviors using an online survey
Hyperphagia means the intense, constant hunger that often occurs in individuals with PWS
Time frame: Up to 4 years
Evaluate hyperphagia management using an online survey
Time frame: Up to 4 years
Evaluate food-related behaviors using an online survey
Time frame: Up to 4 years
Analyze medical information to evaluate the natural history of PWS
Medical information will be from birth to before enrolling in the study
Time frame: Up to 4 years
Plan to share: Yes — FPWR allows for registry use by request and releases de-identified data to the public.
Access criteria: Data access will be governed by the Global PWS Registry advisory board.
Ran from Sep 2018 to primary completion in Jan 2024, 64 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Foundation for Prader-Willi Research